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International concern is growing regarding antimicro-
bial drug resistance in Shigella infections associated with 
India. Fluoroquinolone resistance emerged in S. dysente-
riae in 2002, in S. flexneri in 2004, and in S. sonnei in 2007 
(5). Studies from Japan have also reported an association 
between travel to India and infection with an S. sonnei 
clonal group that was multidrug resistant, including resis-
tance to nalidixic acid (6). Furthermore, ciprofloxacin-re-
sistant S. sonnei isolates from foodborne outbreaks in India 
in 2009 and 2010 (7) had XbaI- PFGE types and resistance 
profiles visually indistinguishable from those reported in 
our study. A study of S. sonnei isolates in Bhutan showed 
that this clonal group was also common there (8). Further-
more, a 2010 outbreak of ciprofloxacin-resistant S. sonnei 
in Canada associated with men who have sex with men 
showed XbaI- and BlnI-PFGE patterns that appear similar 
to the patterns for isolates in this study (9).
Antimicrobial drug resistance is a major global prob-
lem that is likely to be exacerbated in places with poor sani-
tation and intensive use of antimicrobial drugs in humans 
and animals. These factors have contributed to increased 
ciprofloxacin resistance in Salmonella enterica serovars 
Typhi and Paratyphi A (10).
A review of published literature and informal com-
munication indicates that our observation of ciprofloxacin 
resistance in S. sonnei infections associated with travel to 
India is part of a general global trend. This increasing resis-
tance suggests that ciprofloxacin may no longer be suitable 
for empiric therapy for S. sonnei infection, particularly for 
patients with a history of travel to the subcontinent of India.
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To the Editor: Balamuthia mandrillaris is a free-
living ameba that has a worldwide distribution in soil and 
was first reported in 1990 (1). Approximately 200 B. man-
drillaris meningoencephalitis cases have been described, 
mostly from warm climate areas in South America. Its 
prevalence in the United States is estimated to be 1 case/
year (2). However, B. mandrillaris meningoencephalitis 
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has not been reported in Africa, and only 4 cases have been 
reported in Europe (3–6). Transmission occurs through 
the respiratory tract or the skin or by organ transplant, and 
the incubation period varies from weeks to months after 
primary infection (7). After an indolent, subacute phase 
with aspecific symptoms, the amebae invade the central 
nervous system, and illness rapidly progresses, leading 
almost invariably to death (7). Because B. mandrillaris 
is difficult to detect in soil, its specific geographic distri-
bution around the world is unknown and is estimated on 
the basis of where illnesses have been reported (7). This 
report addresses fatal B. mandrillaris meningoencepha-
litis in a woman from the Netherlands who had visited 
The Gambia.
In December 2013, a previously healthy 61-year-old 
white woman in the Netherlands sought care for fever, head-
aches, and muscle pains she had experienced for 1 week. 
That year, she had traveled 4 times to The Gambia, the 
last visit being 1 month before her hospitalization (online 
Technical Appendix Table 1, http://wwwnc.cdc.gov/EID/
article/21/5/14-1325-Techapp1.pdf). After she returned 
from her visit in September 2013, fatigue, diarrhea, fever, 
and pustular skin lesions on her back and lower extremities 
developed. A wound swab culture showed Staphylococcus 
aureus, for which she was treated successfully with oral 
clarithromycin and topical fucidin ointment.
On admission in December, her physical and neuro-
logic examination results were unremarkable. Malaria was 
excluded; because of persisting headaches, a cerebral com-
puted tomography scan without contrast was performed 
but showed no abnormalities. In the following days, high 
fevers, altered mental status, and nuchal rigidity without 
focal neurologic deficits developed. Cerebrospinal fluid 
(CSF) examination showed mononuclear pleocytosis, high-
ly elevated protein levels, and low glucose levels (online 
Technical Appendix Table 2). Serial cerebral computed to-
mography and magnetic resonance imaging scans showed 
development of an asymmetric hydrocephalus and diffuse 
leptomeningeal and subependymal contrast enhancement, 
especially around the brainstem, without signs of intracere-
bral mass lesions (online Technical Appendix Figure).
Presumed diagnosis was tuberculous meningitis, and 
she was treated with tuberculostatic drugs (isoniazid, ri-
fampin, pyrazinamide, and ethambutol) combined with 
intravenous acyclovir, ceftriaxone, and co-trimoxazole for 
other infectious causes of meningoencephalitis. Despite ex-
ternal lumbar and ventricular (both lateral ventricles and 
fourth ventricle) CSF drainage, her neurologic condition 
deteriorated. Multiple cranial nerve palsies developed, and 
she became comatose and died 11 days after admission.
Informed consent for postmortem examination was 
obtained, and macroscopic pathologic examination showed 
uncal and cerebellar herniation caused by increased in-
tracranial pressure. Microscopic brain tissue examina-
tion showed signs of acute granulomatous inflammation, 
multiple hemorrhagic infarctions, and angiitis in the pres-
ence of numerous amebic trophozoites and cysts (Figure), 
which showed granulomatous hemorrhagic necrotic ame-
bic meningoencephalitis. Real-time PCR and subsequent 
sequencing on brain biopsy and CSF specimens showed B. 
mandrillaris to be the causative ameba (8,9).
The infection could have been acquired in The Gambia 
or the Netherlands because the patient had intensive soil con-
tact in The Gambia, where she frequently cultivated land, and 
in the Netherlands, where she worked in glass horticulture. 
She may have been infected through the skin after contact 
with contaminated soil, but her skin lesions were atypical 
for B. mandrillaris, and postmortem examinations failed to 
identify B. mandrillaris except in the central nervous system.
The lack of reported B. mandrillaris cases from Af-
rica might indicate a low number of postmortem examina-
tions and little access to advanced diagnostics, rather than 
a low environmental prevalence of B. mandrillaris. The 
few reported cases in Europe might be related to lack of 
awareness and to clinical signs and symptoms that mimic 
tuberculous meningitis: a lymphocytic pleocytosis with 
an elevated protein level and a low glucose level in CSF, 
together with a hydrocephalus and subependymal and 
	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	21,	No.	5,	May	2015	 897
LETTERS
Figure.	Postmortem	pathologic	findings	for	woman	in	the	Netherlands	who	died	of	Balamuthia mandrillaris	meningoencephalitis	after	
returning	from	travel	to	The	Gambia.	A)	Macroscopic	coronal	central	section	scan	showing	hemorrhagic	necrotizing	lesions	of	the	
subependymal,	meningeal,	and	parenchymal	areas	of	the	parietotemporal	lobes	(circles	and	arrows).	B)	Low-power	microscopic	scan	
showing	hemorrhagic	necrotizing	angiitis	of	the	meningeal	vessels	(arrow)	(original	magnification	×25).	C)	Medium-power	microscopic	
scan	(original	magnification	×200)	showing	perivascular	trophozoite	cuffing	(arrows)	and	granulomatous	inflammation.	D)	High-power	
microscopic	scan	(original	magnification	×630)	showing	encysted	amebae	(arrows)	and	free	trophozoites	(arrowhead).	Hematoxylin	and	
eosin	stains.	
leptomeningeal contrast enhancement on magnetic reso-
nance imaging (10). Also, B. mandrillaris meningoen-
cephalitis imaging findings are often nonspecific, including 
cerebral edema, hydrocephalus, multiple space-occupying 
and ring-enhancing lesions, leptomeningeal enhancement, 
or formation of mycotic aneurysms (2). Furthermore, ame-
bic trophozoites are seldom detected in CSF by microscopy 
(2,3). Consequently, B. mandrillaris meningoencephalitis 
could be underdiagnosed, especially where this infection 
has no or only sporadic reports.
B. mandrillaris should be considered in refractory or 
unexplained cases of meningoencephalitis, even outside 
the Americas and in immunocompetent patients. Detecting 
B. mandrillaris by PCR in CSF seems most likely to enable 
early diagnosis and timely treatment. However, appropri-
ate therapy is not well defined; success has been sparsely 
reported with the simultaneous use of azoles, flucytosine, 
pentamidine, sulfazidine, macrolide antimicrobial drugs, 
phenothiazines, and miltefosine (2,7,10).
References
  1. Visvesvara GS, Martinez AJ, Schuster FL, Leitch GJ,  
Wallace SV, Sawyer TK, et al. Leptomyxid ameba, a new agent  
of amebic meningoencephalitis in humans and animals.  
J Clin Microbiol. 1990;28:2750–6.
  2. Diaz JH. The public health threat from Balamuthia mandrillaris in 
the southern United States. J La State Med Soc. 2011;163:197–204.
  3. Jayasekera S, Sissons J, Tucker J, Rogers C, Nolder D, Warhurst 
D, et al. Post-mortem culture of Balamuthia mandrillaris from the 
brain and cerebrospinal fluid of a case of granulomatous amoebic 
meningoencephalitis, using human brain microvascular  
endothelial cells. J Med Microbiol. 2004;53:1007–12.  
http://dx.doi.org/10.1099/jmm.0.45721-0
  4. Kodet R, Nohynkova E, Tichy M, Soukup J, Visvesvara GS.  
Amebic encephalitis caused by Balamuthia mandrillaris in a  
Czech child: description of the first case from Europe. Pathol Res 
Pract. 1998;194:423–9. http://dx.doi.org/10.1016/ 
S0344-0338(98)80033-2
  5. Tavares M, Correia da Costa JM, Carpenter SS, Santos LA,  
Afonso C, Aguiar A, et al. Diagnosis of first case of Balamuthia 
amoebic encephalitis in Portugal by immunofluorescence and 
PCR. J Clin Microbiol. 2006;44:2660–3. http://dx.doi.org/10.1128/
JCM.00479-06
  6. White JM, Barker RD, Salisbury JR, Fife AJ, Lucas SB,  
Warhurst DC, et al. Granulomatous amoebic encephalitis. Lancet. 
2004;364:220. http://dx.doi.org/10.1016/S0140-6736(04)16640-3
  7. Matin A, Siddiqui R, Jayasekera S, Khan NA. Increasing 
importance of Balamuthia mandrillaris. Clin Microbiol Rev. 
2008;21:435–48. http://dx.doi.org/10.1128/CMR.00056-07
  8. Qvarnstrom Y, Visvesvara GS, Sriram R, da Silva AJ. Multiplex real-
time PCR assay for simultaneous detection of Acanthamoeba spp., 
Balamuthia mandrillaris, and Naegleria fowleri. J Clin Microbiol.  
2006;44:3589–95. http://dx.doi.org/10.1128/JCM.00875-06
  9. Kiderlen AF, Radam E, Lewin A. Detection of Balamuthia man-
drillaris DNA by real-time PCR targeting the RNase P gene. BMC 
Microbiol. 2008;8:210. http://dx.doi.org/10.1186/1471-2180-8-210
10. Visvesvara GS, Moura H, Schuster FL. Pathogenic and  
opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia 
mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS 
Immunol Med Microbiol. 2007;50:1–26. http://dx.doi.org/10.1111/ 
j.1574-695X.2007.00232.x
Address for correspondence: Jaap J. van Hellemond, Medical 
Microbiology and Infectious Diseases, Erasmus Medical Centre 
and Harbour Hospital, PO Box 2040, NL-3000 CA Rotterdam, the 
Netherlands; email: j.vanhellemond@erasmusmc.nl
898	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	21,	No.	5,	May	2015
LETTERS
 
Sources
  1. Centers for Disease Control and Prevention. Balamuthia man-
drillaris—granulomatous amebic encephalitis (GAE) [cited 
2015 Feb 10]. http://www.cdc.gov/parasites/balamuthia/
  2. Centers for Disease Control and Prevention. Balamuthia 
mandrillaris transmitted through organ transplantation 
—Mississippi, 2009. MMWR Morb Mortal Wkly Rep. 
2010;59:1165–70.
  3. Schuster FL. In memoriam: William Balamuth 
(1914–1981). J Protozool. 1982;29:1–2. http://dx.doi.
org/10.1111/j.1550-7408.1982.tb02872.x
  4. Visvesvara GS, Schuster FL, Martinez AJ. Balamuthia 
mandrillaris, n. g., n. sp., agent of amebic 
meningoencephalitis in humans and other animals.  
J Eukaryot Microbiol. 1993;40:504–14. http://dx.doi.
org/10.1111/j.1550-7408.1993.tb04943.x
A free-living ameba naturally found in the envi-ronment, Balamuthia mandrillaris can cause 
a serious infection of the brain, other organs (skin, 
liver, kidneys), and rarely, spinal cord. Originally 
isolated from the brain of a mandrill that died of 
meningoencephalitis at the San Diego Zoo, Bala-
muthia mandrillaris is named for the late professor 
William Balamuth of the 
University of California at 
Berkeley, for his contributions 
to the study of amebae. More 
recently, B. mandrillaris has 
been shown to be transmissible 
through organ transplantation.
Balamuthia mandrillaris [balʺə-mooʹthe-ə manʺdril-aʹris]
etymologia
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